NOVO-NORDISK A/S-SPONS ADR (NVO) Stock Price, Quote, News and Overview
NYSE:NVO - New York Stock Exchange, Inc. - US6701002056 - ADR - Currency: USD
NVO Quote, Performance and Key Statistics
NYSE:NVO (2/21/2025, 10:14:05 AM)
86.74
+3 (+3.58%)
The current stock price of NVO is 86.74 USD. In the past month the price increased by 3.93%. In the past year, price decreased by -32.17%.
NVO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.51 | 833.17B | ||
| JNJ | JOHNSON & JOHNSON | 16.09 | 386.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.45 | 228.90B | ||
| MRK | MERCK & CO. INC. | 11.51 | 222.41B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.66 | 214.18B | ||
| PFE | PFIZER INC | 8.33 | 146.80B | ||
| SNY | SANOFI-ADR | 13.53 | 135.69B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.45 | 112.03B | ||
| GSK | GSK PLC-SPON ADR | 7.72 | 73.88B | ||
| ZTS | ZOETIS INC | 27.02 | 72.16B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.76 | 44.31B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.12 | 19.61B |
Related stock screener links
About NVO
Company Profile
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Company Info
NOVO-NORDISK A/S-SPONS ADR
Novo Alle 1
Bagsvaerd 2880 DK
CEO: Lars Fruergaard Jorgensen
Employees: 71880
Company Website: https://www.novonordisk.com/
Investor Relations: https://www.novonordisk.com/investors.html
Phone: 4544448888
NOVO-NORDISK A/S-SPONS ADR / NVO FAQ
What is the stock price of NOVO-NORDISK A/S-SPONS ADR today?
The current stock price of NVO is 86.74 USD. The price increased by 3.58% in the last trading session.
What is the ticker symbol for NOVO-NORDISK A/S-SPONS ADR stock?
The exchange symbol of NOVO-NORDISK A/S-SPONS ADR is NVO and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NVO stock listed?
NVO stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for NOVO-NORDISK A/S-SPONS ADR stock?
31 analysts have analysed NVO and the average price target is 123.2 USD. This implies a price increase of 42.04% is expected in the next year compared to the current price of 86.74. Check the NOVO-NORDISK A/S-SPONS ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NOVO-NORDISK A/S-SPONS ADR worth?
NOVO-NORDISK A/S-SPONS ADR (NVO) has a market capitalization of 385.04B USD. This makes NVO a Mega Cap stock.
How many employees does NOVO-NORDISK A/S-SPONS ADR have?
NOVO-NORDISK A/S-SPONS ADR (NVO) currently has 71880 employees.
What are the support and resistance levels for NOVO-NORDISK A/S-SPONS ADR (NVO) stock?
NOVO-NORDISK A/S-SPONS ADR (NVO) has a support level at 78.69 and a resistance level at 87.97. Check the full technical report for a detailed analysis of NVO support and resistance levels.
Is NOVO-NORDISK A/S-SPONS ADR (NVO) expected to grow?
The Revenue of NOVO-NORDISK A/S-SPONS ADR (NVO) is expected to grow by 21.41% in the next year. Check the estimates tab for more information on the NVO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NOVO-NORDISK A/S-SPONS ADR (NVO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NVO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NVO, evaluating the profitability, health, valuation and growth aspects
- NOVO-NORDISK A/S-SPONS ADR (NVO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOVO-NORDISK A/S-SPONS ADR (NVO) Sales and EPS estimates to see what analysts future expectations are.
- NOVO-NORDISK A/S-SPONS ADR (NVO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOVO-NORDISK A/S-SPONS ADR (NVO) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOVO-NORDISK A/S-SPONS ADR (NVO) Stock Chart to make your own analysis
- NOVO-NORDISK A/S-SPONS ADR (NVO) Latest news and press-releases to stay up to date.
Does NOVO-NORDISK A/S-SPONS ADR (NVO) stock pay dividends?
NOVO-NORDISK A/S-SPONS ADR (NVO) has a dividend yield of 2.01%. The yearly dividend amount is currently 9.92. Check the full fundamental report for a detailed analysis of NVO dividend history, reliability and sustainability.
When does NOVO-NORDISK A/S-SPONS ADR (NVO) report earnings?
NOVO-NORDISK A/S-SPONS ADR (NVO) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of NOVO-NORDISK A/S-SPONS ADR (NVO)?
The PE ratio for NOVO-NORDISK A/S-SPONS ADR (NVO) is 27.11. This is based on the reported non-GAAP earnings per share of 3.2 and the current share price of 86.74 USD. Check the full fundamental report for a full analysis of the valuation metrics for NVO.
What is the Short Interest ratio of NOVO-NORDISK A/S-SPONS ADR (NVO) stock?
The outstanding short interest for NOVO-NORDISK A/S-SPONS ADR (NVO) is 0.31% of its float. Check the ownership tab for more information on the NVO short interest.
NVO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NVO. When comparing the yearly performance of all stocks, NVO is a bad performer in the overall market: 89.37% of all stocks are doing better.
NVO Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to NVO. Both the health and profitability get an excellent rating, making NVO a very profitable company, without any liquidiy or solvency issues.
NVO Financial Highlights
Over the last trailing twelve months NVO reported a non-GAAP Earnings per Share(EPS) of 3.2. The EPS increased by 22.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 34.78% | ||
| ROA | 21.68% | ||
| ROE | 70.38% | ||
| Debt/Equity | 0.62 |
NVO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to NVO. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 22% and a revenue growth 21.41% for NVO